Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2290-2295, September 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasmussen, R. E.
Right arrow Articles by Wang, I. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasmussen, R. E.
Right arrow Articles by Wang, I. Y.

Dependence of Specific Metabolism of Benzo(a)pyrene on the Inducer of Hydroxylase Activity1

Ronald E. Rasmussen and Irene Y. Wang

Cancer Research Institute, University of California, San Francisco, California 94143

Adult male Sprague-Dawley rats were treated with polycyclic hydrocarbons, phenobarbital (PB), or barbital and the induced hydroxylase enzymes in liver and lung were studied in terms of the specific metabolites of benzo (a) pyrene (BP) that were produced in an in vitro incubation system. The metabolite profile produced by phenobarbital- or barbital-induced enzymes differed from that found with the hydrocarbon-induced liver enzymes in that only the production of 4,5-dihydro-4,5-dihydroxy-BP and 3-hydroxy-BP was increased over the control level, while the production of all identified metabolites was increased when the hydrocarbons were used as inducers. An exception was benzo (e) pyrene, which was essentially inactive as an inducer for either liver or lung enzymes. PB and barbital did not increase enzyme activity in the lung, but BP, 3-methylcholanthrene (3-MC), and 1,2-benzanthracene did. When the induced liver enzymes were tested for their ability to activate BP to a bacterial mutagen, it was found that the PB-induced enzymes were much more active than the 3-MC-induced enzymes when low levels (less than 1 mg/ml) of enzyme protein were present in the incubation mixtures. At higher levels of enzyme protein, the 3-MC-induced enzymes were more active. Addition of an epoxide hydrase inhibitor, 1,2-epoxy-3,3,3-trichloropropane, to the test mixtures with PB-induced enzymes greatly increased the mutagenic activity but only slightly increased the activity obtained with the 3-MC-induced enzymes. The conclusions were: (a) PB and polycyclic hydrocarbons induce enzymes in rat liver with different specificities toward BP; (b) the induced enzymes activated BP to a form that was mutagenic for bacteria; (c) inhibition of the epoxide hydrase induced by PB allowed the accumulation of a form of BP that was mutagenic for bacteria, probably the 4,5-epoxide.

1 Supported by USPHS Grant CA-11939.

Received 2/25/74. Accepted 5/22/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.